
India's first approved dengue vaccine, Qdenga, received marketing authorization from the Central Drugs Standard Control Organisation in July 2026. The vaccine is approved for individuals between the ages of four and sixty years. The rollout of the vaccine is scheduled to begin in 2027.
Qdenga is India’s first approved dengue vaccine, and in July 2026, it received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for individuals aged 4-60 years
This story was originally reported by The Hindu — Business. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
Crowd-sourced evaluation based on verified reader feedback
No reader evaluations recorded yet — be the first to rate the coverage tone above!
Quick Story Reactions:
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.